Skip to the page

Data / Form D filings / Arkis BioSciences Inc.

Arkis BioSciences Inc.: Form D filings

Arkis BioSciences Inc., a biotechnology company in Knoxville, TN, filed 3 Form D notices with the SEC between 2016 and 2018. The latest, on August 29, 2018, reports $4.5 million sold of a $4.5 million offering to 25 investors.

Find out what Arkis BioSciences Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2704 CHEROKEE FARM WAY, SUITE 204, Knoxville, TN, 37920
Phone
(844) 247-5383
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2016
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1679188

The full lists. Form D filings in Tennessee: 543 rows, $27.15, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 29, 2018New notice$4,483,500$4,483,500$025Jan 11, 2018sec.gov
Aug 29, 2018Amendment$3,352,500$3,352,500$08Jun 17, 2016sec.gov
Jul 11, 2016New notice$3,352,500$2,325,000$1,027,5008Jun 17, 2016sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Quentin A. AtenExecutive Officer
James A. Killeffer, M.D.Executive Officer, Director
Ken A. WoodyDirector
Chad E. SeaverExecutive Officer, Director
Clif A. MoyersDirector
Stephen A. ArnoldExecutive Officer

Other biotechnology companies in Tennessee that filed recently

Every Form D from the week of Aug 27, 2018 · All recent filings in Tennessee · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Arkis BioSciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.